Last reviewed · How we verify
Cataflam® 50 coated tablet
Cataflam® 50 coated tablet is a Small molecule drug developed by Ain Shams University. It is currently FDA-approved.
At a glance
| Generic name | Cataflam® 50 coated tablet |
|---|---|
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Assessment of Different Medications in Modifying the Efficacy of Anesthesia in Mandibular Molars With Acute Irreversible Pulpitis (PHASE4)
- Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet (PHASE1, PHASE2)
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack (PHASE2)
- Delayed Release Diclofenac Sodium Formulation vs Voltaren® (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cataflam® 50 coated tablet CI brief — competitive landscape report
- Cataflam® 50 coated tablet updates RSS · CI watch RSS
- Ain Shams University portfolio CI
Frequently asked questions about Cataflam® 50 coated tablet
What is Cataflam® 50 coated tablet?
Cataflam® 50 coated tablet is a Small molecule drug developed by Ain Shams University.
Who makes Cataflam® 50 coated tablet?
Cataflam® 50 coated tablet is developed and marketed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).
What development phase is Cataflam® 50 coated tablet in?
Cataflam® 50 coated tablet is FDA-approved (marketed).
Related
- Manufacturer: Ain Shams University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing